Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples